Medicine News
Transforaminal steroid injection for lumbar radicular pain proves superior to placebo
| 7/29/2010 | A recent study from Australian researchers determined that transforaminal injection of steroids was a viable alternative to surgery for lumbar radicular pain due to disc herniation. Full details of the study appear in the August issue of Pain Medicine , a journal published by Wiley-Blackwell on behalf of the American Academy of Pain Medicine, the Faculty of Pain Medicine of the Australian and... [Comments] |
Clinical trials can be improved by managing the learning curve
| 7/29/2010 | DURHAM, N.C. Practitioners of clinical medicine are familiar with learning curves, and strategies like simulation are increasingly used to minimize learning-curve effects on clinical care. Because similar learning curves have been hinted at in some clinical trials, researchers at Duke University Medical Center studied the phenomenon in the data record of a large, multi-site clinical trial. Th... [Comments] |
30 million women to benefit from health reform law
| 7/29/2010 | New York, NY, July 30, 2010Thirty million women will benefit from the new health reform law over the next decade, either through new or strengthened insurance coverage, according to a new report from The Commonwealth Fund. In the first analysis of its kind, the authors report that the law will stabilize and reverse the growing exposure to health costs that women now experience by subsidizing h... [Comments] |
Resting brain activity associated with spontaneous fibromyalgia pain
| 7/29/2010 | A recent study from researchers at Massachusetts General Hospital and University of Michigan provides the first direct evidence of linkage between elevated intrinsic (resting-state) brain connectivity and spontaneous pain intensity in patients with fibromyalgia (FM). This research shows an interaction of multiple brain networks, offering greater understanding of how pain arises. Details of th... [Comments] |
Doctors, Patients Rarely on Same Page
| 7/29/2010 | By Jenifer Goodwin HealthDay Reporter THURSDAY, July 29 (HealthDay News) -- Doctors and patients are often out of sync with each other when it comes to what patients believe about their illnesses, including to what extent the patient is to blame and what's the best way to mana... [Comments] |  |
Snake venom studies yield insights for development of therapies for heart disease and cancer
| 7/29/2010 | BETHESDA, Md., July 29, 2010 Researchers seeking to learn more about stroke by studying how the body responds to toxins in snake venom are this week releasing new findings that they hope will aid in the development of therapies for heart disease and, surprisingly, cancer. The Japanese team is reporting in a Journal of Biological Chemistry "Paper of the Week" that they are optimistic th... [Comments] |
Breast Cancer's DNA Yields More Secrets
| 7/29/2010 | By Jenifer Goodwin HealthDay Reporter THURSDAY, July 29 (HealthDay News) -- The genetic makeup of breast cancer tumors may be a better predictor of how well a woman will fare than a tumor's size and appearance, which has been the traditional way of looking at cancers, new rese... [Comments] |  |
Experts Support FDA Panel's Backing of New Blood Thinner
| 7/29/2010 | By Steven Reinberg HealthDay Reporter THURSDAY, July 29 (HealthDay News) -- Following a federal health panel's endorsement of the new blood thinner Brilinta Wednesday, cardiologists say the drug could be a welcome addition to treatments for heart patients. In a 7-to-1 vote, t... [Comments] |  |
UCLA scientists for the first time identify a cell-of-origin for human prostate cancer
| 7/29/2010 | UCLA scientists have identified for the first time a cell-of-origin for human prostate cancer, a discovery that could result in better predictive and diagnostics tools and the development of new and more effective targeted treatments for the disease. The researchers, from UCLA's Jonsson Comprehensive Cancer Center, proved that basal cells found in benign prostate tissue could become human... [Comments] |
A new ground zero for prostate cancer
| 7/29/2010 | A type of prostate cell that has been largely ignored by cancer researchers can, in fact, trigger malignant prostate cancer, according to new studies by Howard Hughes Medical Institute (HHMI) scientists and their colleagues. HHMI researcher Owen N. Witte and his colleagues at the University of California, Los Angeles (UCLA) found that the somewhat overlooked prostate basal cell can spawn... [Comments] |
(Date:7/29/2010)... for the first time a cell-of-origin for human ... better predictive and diagnostics tools and the development ... the disease. , The researchers, from UCLA,s Jonsson ... in benign prostate tissue could become human prostate ... finding that bucks conventional wisdom. It had been ...
(Date:7/29/2010)... N.Y. -- Hockey fans likely would assume that body-checking ... causes the most injuries in youth ice hockey. But ... study, the largest and most comprehensive analysis to date ... overall injuries were caused by accidentally hitting the boards ... by a puck. , Only 34 percent of the ...
(Date:7/29/2010)... publishing the mnemonic "ABCD" to facilitate the early diagnosis ... moniker says early detection remains a key factor in ... and colleagues from the Ronald O. Perelman Department of ... that, despite all of the advances in melanoma diagnosis, ... critical. Their report appears online on CA First Look, ...
(Date:7/29/2010)... Amanda Gardner HealthDay Reporter , , WEDNESDAY, July 28 ... able to grow an entire joint from stem cells, albeit ... rabbits were able to hop and walk and bear weight, ... of a paper published online July 29 in The ... joint with restored functioning." If replicated in humans, the ...
(Date:7/29/2010)... Public immunization efforts may be much more sensitive than ... or risks of vaccination, scientists at Harvard University report ... avoidance via social networks can make the difference between ... as large. , The finding, published in Proceedings ... of the worst pertussis outbreaks in 50 years, in ...
Breaking Medicine News(10 mins):Health News:UCLA scientists for the first time identify a cell-of-origin for human prostate cancer 2Health News:UCLA scientists for the first time identify a cell-of-origin for human prostate cancer 3Health News:Most youth hockey injuries caused by accidents, not checking, UB study shows 2Health News:The evolution of melanoma diagnosis: 25 years beyond the ABCDs 2Health News:Scientists Use Stem Cells to Help Rabbits Grow New Joints 2Health News:Scientists Use Stem Cells to Help Rabbits Grow New Joints 3Health News:Small increases in vaccine cost can cause large gaps in protection 2[0] UCLA scientists for the first time identify a cell-of-origin for human prostate cancer[1] Most youth hockey injuries caused by accidents, not checking, UB study shows[0] The evolution of melanoma diagnosis: 25 years beyond the ABCDs[0] Scientists Use Stem Cells to Help Rabbits Grow New Joints[0] Small increases in vaccine cost can cause large gaps in protection
... Dec. 13 Robert Klaus, President and CEO ... an Outstanding,Public Advocacy Award from the Friends of ... "Robert Klaus,s contributions on behalf of oral ... country," said Peter Anas,Executive Director, NIDCR. "He has ...
... for the Hospital,s ... State-of-the-Art Cardiothoracic Center, SANTA CLARA, Calif., Dec. ... a new network,infrastructure to support a trust-wide Picture Archiving ... Hospitals, part,of the NHS Foundation Trust in Essex, United ...
... Exchange(R),(Amex(R)) today lists the common stock and units of ... QGP.U. One unit consists of three shares of,common stock, ... Warrants,(QGP.WS.B). The common stock and units will be listed ... a later date upon separation of the,unit., The ...
... The chances of infection are boosted 50-fold to 100,000-fold, study ... discovery that perplexes HIV experts, an international team reports that ... of the virus to do its damage. , According to ... , the fibers capture the virus and then ferry it ...
... shows blocking this dependence could stop disease before it ... to certain growth factors contributes to the development of ... activation of a normally silent gene, scientists say. , ... blocking this addiction might help prevent cancer growth. ...
... to see, the mammalian eye also detects light for a ... the timing of the sleep/wake cycle, which is synchronized by ... hypothalamus. , In a study published online on December ... humans whose non-visual responses to light remain intact, suggesting that ...
Other Medicine News:Health News:Oral Health America's Robert Klaus Honored for Outstanding Public Advocacy 2Health News:Extreme Networks Provides Resilient Wired and Wireless Network to the UK's Basildon & Thurrock Hospital 2Health News:Extreme Networks Provides Resilient Wired and Wireless Network to the UK's Basildon & Thurrock Hospital 3Health News:American Stock Exchange Lists the Common Stock and Units of The Quantum Group, Inc. 2Health News:Fibers in Semen Help HIV Penetrate Cells 2Health News:Cell 'Addiction' to Growth Factors May Help Spur Cancers 2Health News:Blind humans lacking rods and cones retain normal responses to non-visual effects of light 2Health News:Blind humans lacking rods and cones retain normal responses to non-visual effects of light 3Oral Health America's Robert Klaus Honored for Outstanding Public AdvocacyExtreme Networks Provides Resilient Wired and Wireless Network to the UK's Basildon & Thurrock HospitalAmerican Stock Exchange Lists the Common Stock and Units of The Quantum Group, Inc.Fibers in Semen Help HIV Penetrate CellsCell 'Addiction' to Growth Factors May Help Spur CancersBlind humans lacking rods and cones retain normal responses to non-visual effects of light
... is a formulation of iopamidol ... by oral administration or, where necessary, ... considerable improvement in the radiological exploration ... traditional contrast media. Thanks to its ...
... dimeglumine) is a paramagnetic MRI contrast agent. ... gadobenate, a chelating agent that forms a ... ion. It is salified with meglumine forming ... all the physico-chemical features typical of gadolinium ...
... GastroMARK (generic name: ferumoxsil) is Advanced ... distinguish the loops of the bowel from ... of organs and tissues in the abdomen ... organs and tissues cannot be easily distinguished ...
... Up to 20% of the ... the U.S. are suboptimal. Activated DEFINITY ... clearer images of the heart than ... activated DEFINITY improves diagnostic quality for ...
Medicine Products:(Date:7/29/2010)... , July 29 Shionogi Inc., a ... the U.S. Food and Drug Administration approval of CUVPOSA™ (glycopyrrolate), ... from chronic severe drooling associated with neurologic conditions such as ... FDA. , , ... "The FDA approval of CUVPOSA provides parents and caregivers ...
(Date:7/29/2010)... July 29 AVANIR Pharmaceuticals, Inc. ... release unaudited fiscal third quarter financial results for the ... before market open on Thursday, August 5, ... Randall Kaye , M.D., Senior Vice President and ... President, Finance, will host an investment community conference call ...
(Date:7/29/2010)... China , July 29 /PRNewswire-Asia/ -- Winner ... Company"), a leading manufacturer of medical,dressings, medical disposables and ... announced today that it opened its,first online PurCotton(R) store ... http://purcotton.mall.taobao.com/ . , ... ...
Breaking Medicine Technology:Shionogi Inc. Announces FDA Approval of CUVPOSA™ for the Treatment of Chronic Severe Drooling in Pediatric Patients With Neurologic Conditions 2Shionogi Inc. Announces FDA Approval of CUVPOSA™ for the Treatment of Chronic Severe Drooling in Pediatric Patients With Neurologic Conditions 3Shionogi Inc. Announces FDA Approval of CUVPOSA™ for the Treatment of Chronic Severe Drooling in Pediatric Patients With Neurologic Conditions 4AVANIR Pharmaceuticals Invites Investors to Fiscal 2010 Third Quarter Conference Call 2Winner Medical Launches Its First Online PurCotton(R) Store in China on Taobao.com 2Winner Medical Launches Its First Online PurCotton(R) Store in China on Taobao.com 3Winner Medical Launches Its First Online PurCotton(R) Store in China on Taobao.com 4Winner Medical Launches Its First Online PurCotton(R) Store in China on Taobao.com 5Regado Biosciences to Present at the BioPharm America 2009 Conference on September 17 2009 14051 1Regado Biosciences to Present at the BioPharm America 2009 Conference on September 17 2009 14051 2The Uptake of Novel Therapies Will Drive the Obesity Drug Market to Increase More than Six Fold to Over 243 2 Billion in 2018 57174 1The Uptake of Novel Therapies Will Drive the Obesity Drug Market to Increase More than Six Fold to Over 243 2 Billion in 2018 57174 2The Uptake of Novel Therapies Will Drive the Obesity Drug Market to Increase More than Six Fold to Over 243 2 Billion in 2018 57174 3Dr Dorin Panescu NewCardios Chief Technology Officer Awarded Professional Career Achievement Award by the IEEE Engineering in Medicine and Biology 57169 1Dr Dorin Panescu NewCardios Chief Technology Officer Awarded Professional Career Achievement Award by the IEEE Engineering in Medicine and Biology 57169 2Dr Dorin Panescu NewCardios Chief Technology Officer Awarded Professional Career Achievement Award by the IEEE Engineering in Medicine and Biology 57169 3Dr Dorin Panescu NewCardios Chief Technology Officer Awarded Professional Career Achievement Award by the IEEE Engineering in Medicine and Biology 57169 4Dr Dorin Panescu NewCardios Chief Technology Officer Awarded Professional Career Achievement Award by the IEEE Engineering in Medicine and Biology 57169 5[0] Shionogi Inc. Announces FDA Approval of CUVPOSA™ for the Treatment of Chronic Severe Drooling in Pediatric Patients With Neurologic Conditions[0] AVANIR Pharmaceuticals Invites Investors to Fiscal 2010 Third Quarter Conference Call[0] Winner Medical Launches Its First Online PurCotton(R) Store in China on Taobao.com
... validate efficacy of the processTHOUSAND OAKS, Calif., Feb. 24 ... successfully completed the initial primate trials validating the efficacy ... in spinal fusion surgery. 100% fusion was obtained ... was observed. The company is currently preparing Pre-IDE ...
... Feb. 24 BioTrends is pleased to announce the fielding of ... (R) . Takeda Pharmaceutical Company Limited announced that they ... febuxostat) on February 13, 2009. Uloric (R) ... and represents the first product for gout that has been approved ...
Other Medicine Technology:Bone Biologics Announces Significant Milestone for Spinal Fusion Surgery Using Recombinant Protein and Demineralized Bone Matrix 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |